$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
有了Enfortumabvedotin-ejfv 尿路上皮癌患者王先生工作不再尴尬
2025-10-19 11:44:20
Check Details
厄达替尼用法用量是怎样的?厄达替尼的副作用是什么?
2025-10-19 11:44:20
Check Details
尿路上皮癌新药-Padcev
2025-10-19 11:44:20
Check Details
Padcev现在在南昌可以购买到吗?
2025-10-19 11:44:20
Check Details
欧盟专家组确认Padcev用于局部晚期或转移性尿路上皮癌的建议
2025-10-19 11:44:20
Check Details
Enfortumab vedotin-ejfv治疗局部晚期或转移性尿路上皮癌
2025-10-19 11:44:20
Check Details
Enfortumab vedotin-ejfv需要静脉输注吗?要注意什么
2025-10-19 11:44:20
Check Details
尿路上皮癌首款ADC药物——Padcev在欧盟即将获批
2025-10-19 11:44:20
Check Details
Enfortumab vedotin-ejfv是什么药?可以用医保购买吗?
2025-10-19 11:44:20
Check Details
吃厄达替尼能活多久,疗效好吗?
2025-10-19 11:44:20
Check Details
恩诺单抗2022最新价格,多少钱一支?
2025-10-19 11:44:20
Check Details
恩诺单抗治疗尿路上皮癌:Ⅱ期多中心研究中客观缓解率为44%!
2025-10-19 11:44:20
Check Details
1
2
...
51
52
53
54
55
56
57
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
2
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
3
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
4
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
5
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
6
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
7
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
8
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
9
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
10
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
11
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
12
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?